Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney

Yunyi Yan1, Nozomi Kondo1, Kentaro Oniki1

  • 1Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Insights

Visit-to-visit variability in glycated hemoglobin (HbA1c) is linked to diabetic kidney disease (DKD) risk. The HbA1c area under the curve (HbA1c-AUC) shows promise as a prognostic indicator for microalbuminuria in type 2 diabetes.

Area of Science:

  • Endocrinology
  • Nephrology
  • Metabolic Disorders

Background:

  • Glycemic control is crucial for managing type 2 diabetes mellitus (T2DM).
  • Visit-to-visit variability in glycated hemoglobin (HbA1c) has emerged as a potential risk factor for diabetic complications.
  • Diabetic kidney disease (DKD) is a major microvascular complication of diabetes, characterized by albuminuria.

Purpose of the Study:

  • To investigate the association between different measures of visit-to-visit HbA1c variability and the risk of developing or progressing diabetic kidney disease (DKD).
  • To identify the most effective index for quantifying HbA1c variability in predicting DKD risk.
  • To explore the role of oxidative stress in this relationship.

Main Methods:

  • A clinic-based retrospective longitudinal study involving 699 Japanese patients with T2DM.
  • Calculation of HbA1c variability using HbA1c standard deviation (HbA1c-SD), coefficient of variation (HbA1c-CV), change score (HbA1c-HVS), and area under the curve (HbA1c-AUC) over 3 years.
  • Cox proportional hazards models, propensity score matching, and bootstrap analyses were employed to assess associations with DKD incidence and progression.

Main Results:

  • Both HbA1c-SD and HbA1c-AUC were significantly associated with the incidence of microalbuminuria, independent of mean HbA1c levels.
  • These findings were robust and replicated across different statistical analyses.
  • Elevated HbA1c-SD and HbA1c-AUC were also correlated with higher levels of oxidized human serum albumin (HSA), a marker of oxidative stress.

Conclusions:

  • Visit-to-visit HbA1c variability is an independent risk factor for microalbuminuria in T2DM patients, potentially mediated by oxidative stress.
  • The HbA1c-AUC, a novel variability index, demonstrates potential as a prognostic indicator for predicting microalbuminuria risk.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
229
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
9
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
911
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
101
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K